End Tuberculosis Now Act of 2026

Bill Number

S. 4751

Origin Chamber

Senate

Congress

119th Congress, Session 2

Policy Area

International Affairs

Status

Introduced

Latest Action

2026-06-11: Read twice and referred to the Committee on Foreign Relations.

Last Updated

2026-07-02T20:45:27Z

AI-Generated Summary

Summary of S. 4751: End Tuberculosis Now Act of 2026

Purpose of the Legislation

This bill amends the Foreign Assistance Act of 1961 to authorize and expand U.S. assistance for preventing, treating, and eliminating tuberculosis (TB) worldwide. It aims to end the global TB public health emergency by supporting diagnosis, treatment, prevention, and research, while aligning with the America First Global Health Strategy.

Key Provisions Outlined

• Findings and Policy Objectives: Recognizes TB as a continuing global challenge and sets major goals to diagnose and treat all forms of TB, prevent new infections, reduce mortality and incidence rates, and integrate TB efforts into broader health systems.
• Authorization of Assistance: Empowers the President to provide aid on terms deemed necessary, with priorities including building TB programs, treating co-infections like HIV, strengthening health systems, developing new diagnostics and vaccines, and supporting sustainable procurement of quality TB commodities.
• Goals Establishment: Directs the President to set targets for 2027–2030, such as an 80% reduction in TB incidence and 90% reduction in mortality (from 2015 levels), diagnosing 90% of cases, achieving 90% treatment success, and providing preventive treatment to 30 million people; also requires updating the National Action Plan for Multidrug-Resistant TB.
• Coordination Requirements: Mandates consultation with partner nations, international organizations, NGOs, and the private sector; emphasizes bilateral assistance to catalyze research, focus on high-burden countries, and avoid duplication among U.S. agencies.
• Support for Partnerships: Authorizes resources for monitoring TB data, direct aid to high-TB countries for local capacity building, and leveraging donor contributions.
• Reporting Obligations: Requires annual reports on U.S. TB assistance activities (through 2032 or until goals are met), research and development progress, and a one-time evaluation by the Comptroller General on program performance and impact.
• Sunset Clause: The amended provisions expire on January 1, 2033.

Significant Changes to Existing Law Introduced

The bill replaces the prior version of Section 104B with a more detailed framework that expands TB-specific policies, introduces measurable global goals aligned with 2030 targets, adds requirements for person-centered care and infection control, mandates integration with primary health care and pandemic response platforms, and imposes new annual reporting on metrics like case detection, treatment outcomes, and commodity procurement challenges.

Potential Impacts

• On Government Agencies: Increases responsibilities for the Department of State, CDC, and other federal entities in coordinating international TB efforts, tracking expenditures, and ensuring accountability; may require additional resources for research coordination and reporting.
• On Citizens: Primarily affects individuals in high-TB countries through improved access to diagnosis, treatment, and prevention; U.S. citizens may see indirect effects via global health stability and reduced pandemic risks.
• On International Relations: Strengthens U.S. engagement with high-burden nations, the Global Fund, and private sector partners; supports health diplomacy while emphasizing U.S. priorities in global health funding and commodity quality standards.

Main Stakeholders Affected

• U.S. executive branch agencies (e.g., State Department, CDC).
• Countries with high TB rates and their national health systems.
• TB patients, high-risk groups (e.g., children, HIV-positive individuals, migrants), and healthcare workers.
• International organizations, NGOs, private sector entities involved in TB research and aid.
• U.S. Congress through oversight of foreign assistance and reports.

Notable Legal, Constitutional, or Political Implications

The legislation expands executive authority in foreign assistance under the Foreign Assistance Act while requiring congressional consultation on goals and annual reporting, raising no direct constitutional conflicts but highlighting separation of powers in foreign policy execution. It may influence political debates on U.S. global health spending priorities and accountability mechanisms for international aid programs.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Sen. Young, Todd [R-IN]

Cosponsors (1)

Sen. Shaheen, Jeanne [D-NH]

Recent Actions

• 2026-06-11: Read twice and referred to the Committee on Foreign Relations.
• 2026-06-11: Introduced in Senate

Bill Versions

• End Tuberculosis Now Act of 2026 — issued 2026-06-11 — PDF (22 pages)